Abbott Laboratories Recalls 359 Million Diabetes Test Strips

Before you go, we thought you'd like these...
Before you go close icon

Abbott Laboratories (ABT) on Wednesday began a recall of approximately 359 million blood-sugar test strips for diabetics. The strips, which are Abbott's Precision Xtra, Precision Xceed Pro, MediSense Optium, Optium, OptiumEZ and ReliOn Ultima blood-glucose monitoring systems, turned out to yield falsely low blood-sugar measurements

The danger is that users may not realize when their blood-sugar levels are too high or may mistakenly boost their blood sugar when it's not necessary.

Both the FDA and the company are reviewing the manufacturing process for the strips. Abbott sold the recalled strips in the U.S. and Puerto Rico between January and September of this year, according to the U.S. Food and Drug Administration (FDA).

Abbott's diabetes treatment products account for about 4% of the company's sales. Shares of the company had dipped 0.3% to $47.84 by about 7 p.m. Wednesday.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners